Amanda Walker

Learn More
PURPOSE To evaluate clinical activity and target modulation of vandetanib in women with recurrent ovarian cancer. EXPERIMENTAL DESIGN A phase II trial of orally administered vandetanib 300 mg daily(More)
OBJECTIVE To gain an understanding of how advance care planning (ACP) is understood and approached by managers of residential aged care facilities. METHODS Qualitative interviews with managers from(More)